CHANGES IN THE LEVELS OF INTERLEUKINS 6 AND 10 AND WATER-SALT HOMEOSTASIS IN THE DEVELOPMENT OF POST-LOADING PROTEINURIA
https://doi.org/10.24884/1561-6274-2003-7-4-46-50
Abstract
THEAIM of the work was to elucidate the possible role of changes in the levels of IL 6 and 10 and certain indices of water-salt homeostasis in the appearance of post-loading proteinuria (PLP) in miners working in deep coal mines. PATIENTSAND METHODS. The investigation was performed on 72 workers in a deep mine after a preliminary medical examination. The examined were divided into 2 groups: I - subjects without proteinuria after shift, Il - subjects with symptoms of proteinuria (albumin from 0.1 to 0.2 g/l) after shift. Control group consisted of 20 practically healthy subjects not engaged in underground workings. Contentof electrolytes (K +, Cl -, Na +) in blood and urine was determined by the method of flame photometry by a conventional technique. The level of creatinine in blood and urine was determined by the Popper method. The glomerular filtration rate (GFR) was calculated by the endogenous creatinine clearance using the Cocroft-Gault formula. Concentration of IL 6 and 10 in blood plasma was investigated by ELISA immunoenzyme analysis. RESULTS. The investigations performed in the group of miners with post-loading proteinuria have revealed appreciably changed indices of water-salt homeostasis and levels of IL 6 and I0 which were aggravated during the shift. CONCLUSION. The intensified interaction between different components of water-salt homeostasis and expression of IL in subjects with PLP testifies to a considerable strain of the body mechanisms responsible for maintaining homeostasis.
About the Authors
B. A. Rebrov
Луганский государственный медицинский университет
Ukraine
Ukraine
V. Ya. Plotkin
Луганский государственный медицинский университет
Ukraine
Ukraine
V. N. Smirnov
Луганский государственный медицинский университет
Ukraine
Ukraine
A. R. Voloshinovich
Луганский государственный медицинский университет
Ukraine
Ukraine
References
1. Арефьева Н.А., Азнабаева Л.Ф., Коваленко А.Л. и др. Продукция цитокинов у больных риносинуситом при лечении циклофероном. Лечащий врач 2000; 4: 71-73
2. Bermudez EA, Rifai N, Buring J. Interrelationshipsamong circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arteriosclerosi, Trombosis and Vascular Biology 2002; 22:1668
3. Anguaera J, Miranda-Guardiola F, Bosch X. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and descreased risk of coronary events in patients with unstable angina. Am Heart J 2000; 144(5): 811-817
4. Яковлева HB. Особенности респираторных вирусных инфекций и клеточного иммунитета при острой и хронической бронхолегочной патологии. Автореф.дис.. доктора мед.наук. СПб 1995
5. Kitching AR, Tipping PG, Huang XR et al. Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int 1997; 52 (1):52-9
6. Niemir Zl, Ondracek M1 Dworacki G et al. In situ upregulation of IL-10 reflects the activity of human glomerulonephritides. Am J Kidney Dis 1998; 32 (1):80-92
7. Tullus K. et al. Soluble receptors to tumor necrosis factor and interleukine-6 in urine during acute pyelonephritis. Acta Paediatr 1997; 86; 1198-1202
8. Fournier A, Achard J. Mnemotechnical note on the use of Cockcroft creatinine clearance formula for the validation of a 24-h urine collection. Nephrol Dial Transplant 2000; 15 (10): 1677-1678
9. Berger S, Ballo H, Stutte HJ. Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro-and anti-inflammatory cytokines dependent on the antigen: antibody ratio. Eur J Immunol 1996; 26(6):1297-301
10. Jacobson SH, Lu Y, Brauner A. Soluble interleukin-6 receptor, interleukin-10 and granulocyte colony-stimulating factor in acute pyelonephritis: relationship to markers of bacterial virulence and renal function. Nephron 1998; 80 (4): 401
11. Rovin B. Chemokines as therapeutic targets in renal inflammation. Am J Kidney Dis 1999; 34(4): 761-767
12. Drazan KE, Wu L, Bullington D, Shaked A. Viral IL-10 gene therapy inhibits TNF-a and IL-1 b, not lL-6, in the newborn endotoxemic mouse. J Pediatr Surg 1996; 31 (3): 411-414
13. Yu CL, Sun KH, Tsai CY et al. Anti-dsDNA antibody up-regulates interleukin 6, but not cyclooxygenase, gene expression in glomerular mesangial cells: a marker of immune-mediated renal damage? Infiamm Res 2001; 50 (1); 12-8
14. Klein B. Update of gp130 cytokines in multiple myeloma. Curr Opin Haematol 1998; 5: 186-91
15. Chadban SJ, Tesch GH, Lan HY et al. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats. Kidneylnt 1997; 51 (6): 1809-17
16. Williams JA, Pontzer CH1 Shacter E. Regulation of macrophage interleukin-6 (IL-6) and IL-10 expression by prostaglandin E2: the role of p38 mitogen-activated protein kinase. J Interferon Cytokine Res 2000; 20(3):291 -8
17. Кашкин КП. Цитокины иммунной системы: основные свойства и иммунобиологическая активность. Клин лаб диагностика 1998; 11:21-32
Review
For citations:
Rebrov B.A., Plotkin V.Ya., Smirnov V.N., Voloshinovich A.R. CHANGES IN THE LEVELS OF INTERLEUKINS 6 AND 10 AND WATER-SALT HOMEOSTASIS IN THE DEVELOPMENT OF POST-LOADING PROTEINURIA. Nephrology (Saint-Petersburg). 2003;7(4):46-50. (In Russ.) https://doi.org/10.24884/1561-6274-2003-7-4-46-50
Views:
318
Email this article 